KLF4调节腹腔大动脉动脉瘤形态和删除减弱动脉瘤的形成
Morgan Salmon1, William F Johnston, Andrew Woo
1Department of Surgery (M.S., W.F.J., A.W., N.H.P., G.S., G.R.U., G.A.) and The Robert M. Berne Cardiovascular Research Center (G.R.U., G.K.O., G.A.), University of Virginia School of Medicine, Charlottesville, VA.
Circulation
|September 14, 2013
概括
克鲁佩尔样因子4 (KLF4) 在腹腔大动脉动脉瘤 (AAA) 的发展中至关重要. 准光滑肌细胞中的KLF4可能为AAA疾病提供新的治疗策略.
科学领域:
- 血管生物学 血管生物学
- 分子医学是分子医学.
背景情况:
- 众所周知,克鲁佩尔样因子4 (KLF4) 在血管损伤后调解炎症反应.
- KLF4在腹腔大动脉动脉瘤 (AAA) 病变发生中的特定作用以前没有被阐明.
研究的目的:
- 研究KLF4在实验AAA形成中的作用.
- 在AAA的背景下,确定KLF4对光滑肌肉 (SM) 细胞的影响.
主要方法:
- 在小鼠中利用弹性酶和血管酶II诱导的AAA模型,具有全球和光滑肌特异性KLF4淘汰.
- 采用了包括西方涂抹,免疫组织化学和染色体免疫沉在内的技术.
- 在人类AAA组织和体外细胞培养实验中验证的结果.
主要成果:
- 在小鼠和人类的AAA发育过程中,KLF4的表达显著增加,局限于SM细胞.
- 失去了KLF4等位基因,特别是在SM细胞中,对AAA形成提供了显著的保护.
- KLF4缺乏减轻了弹性质降解,炎症细胞透和促炎细胞因子的产生,同时保持了SM基因表达.
结论:
- KLF4在AAA病变发生过程中发挥着关键作用,主要是通过其对光滑肌肉细胞的影响.
- KLF4调节了SM细胞的表型切换,这表明它是AAA疾病的潜在治疗标.
相关概念视频
Aneurysm I: Introduction
658
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
658
Aneurysm III: Interprofessional Care
478
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478


